Amedeo's Top 20

Amedeo Smart

Independent Medical Education

11 September 2023

Multidisciplinary Journal Club

  1. Speakman JR, Sorensen TIA, Hall KD, Allison DB, et al.
    Unanswered questions about the causes of obesity.
    Science 2023;381:944-946.

  1. Majoie CB, Cavalcante F, Gralla J, Yang P, et al.
    Value of intravenous thrombolysis in endovascular treatment for large-vessel anterior circulation stroke: individual participant data meta-analysis of six randomised trials.
    Lancet 2023.

  2. Rugo HS, Bardia A, Marme F, Cortes J, et al.
    Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial.
    Lancet 2023.

  3. Giovanella L, D'Aurizio F, Algeciras-Schimnich A, Gorges R, et al.
    Thyroglobulin and thyroglobulin antibody: an updated clinical and laboratory expert consensus.
    Eur J Endocrinol 2023;189:R11-R27.

  4. Kenmotsu H, Yamamoto N, Misumi T, Yoh K, et al.
    Five-Year Overall Survival Analysis of the JIPANG Study: Pemetrexed or Vinorelbine Plus Cisplatin for Resected Stage II-IIIA Nonsquamous Non-Small-Cell Lung Cancer.
    J Clin Oncol 2023.

  1. Reddy VY, Gerstenfeld EP, Natale A, Whang W, et al.
    Pulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation.
    N Engl J Med 2023.

  2. Ayala IN, Soto Jacome C, Toro-Tobon D, Golembiewski E, et al.
    Appropriateness of Levothyroxine Prescription: A Multicenter Retrospective Study.
    J Clin Endocrinol Metab 2023.

  3. Vinding NE, Butt JH, Lauridsen MD, Kristensen SL, et al.
    Long-term Incidence of Ischemic Stroke Following Transient Ischemic Attack: A Nationwide Study During 2014-2020.
    Circulation 2023.

  4. Vidyasagaran AL, Readshaw A, Boeckmann M, Jarde A, et al.
    Is tobacco use associated with risk of recurrence and mortality among people with tuberculosis? A systematic review and meta-analysis.
    Chest 2023.

  5. Koopmann BDM, Dunnewind N, van Duuren LA, Lansdorp-Vogelaar I, et al.
    The natural disease course of pancreatic cyst associated neoplasia, dysplasia, and ductal adenocarcinoma; results of a microsimulation model.
    Gastroenterology 2023.

  1. Monteiro C, Toth B, Brunstein F, Bobbala A, et al.
    A Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants with Mild-to-Moderate Alzheimer's Disease (Lauriet).
    Neurology 2023.

  2. Knop FK, Aroda VR, do Vale RD, Holst-Hansen T, et al.
    Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Lancet 2023.

  3. Ha EJ, Lee JH, Lee DH, Moon J, et al.
    Artificial Intelligence Model Assisting Thyroid Nodule Diagnosis and Management: A Multicenter Diagnostic Study.
    J Clin Endocrinol Metab 2023.

  4. Jarosova J, Zarivnijova L, Cibulkova I, Mares J, et al.
    Endoluminal radiofrequency ablation in patients with malignant biliary obstruction: a randomised trial.
    Gut 2023.

  5. Gaist D, Garcia Rodriguez LA, Hallas J, Hald SM, et al.
    Association of Statin Use With Risk of Stroke Recurrence After Intracerebral Hemorrhage.
    Neurology 2023.

  1. Kang X, Ploner A, Roelstraete B, Ludvigsson JF, et al.
    Risk of Parkinson's disease in celiac disease: A Swedish population-based study.
    Ann Neurol 2023.

  2. Sanft T, Harrigan M, McGowan C, Cartmel B, et al.
    Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study.
    J Clin Oncol 2023.

  3. Joosten LPT, van Doorn S, van de Ven PM, Kohlen BTG, et al.
    Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial.
    Circulation 2023.

  4. van den Born JC, Meziyerh S, Vart P, Bakker SJL, et al.
    Comparison of 2 Immunosuppression Minimization Strategies in Kidney Transplantation: The ALLEGRO Trial.
    Transplantation 2023.

  5. Heerspink HJL, Greasley PJ, Ahlstrom C, Althage M, et al.
    Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease: study design and baseline characteristics of the ZENITH-CKD trial.
    Nephrol Dial Transplant 2023.


more..

Privacy Policy